Martin P. Klein
Martin P. Klein's purchase track record
Martin P. Klein has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/12/2022 | ATHS | $500K | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
Life Insurance Sector Sees Q2 Premium Growth. The life insurance sector reported Q2 gains driven by premium growth, which may reflect increased demand for retirement and savings products. Athene, as a company focused on retirement savings, operates within this sector and may benefit from the same market dynamics. Separately, high-yield preferred stocks continue to attract attention as alternatives to CDs, suggesting sustained investor interest in higher-yielding fixed income products like the Athene debentures.
Transaction History
| MTG | ▲ Buy | Grant | 36 | — | 8/20/2026 | View on chart |
| MTG | ▲ Buy | Grant | 37 | — | 5/21/2026 | View on chart |
| MTG | ▲ Buy | Grant | 36 | — | 3/6/2026 | View on chart |
| MTG | ▲ Buy | Grant | 5,077 | — | 2/4/2026 | View on chart |
| MTG | ▲ Buy | Grant | 7 | — | 11/20/2025 | View on chart |
| MTG | ▲ Buy | Grant | 1,324 | $36K | 10/31/2025 | View on chart |
| ATHS | ▲ Buy | Open Market | 20,000 | $500K | 12/12/2022 | View on chart |
| ATHS | ▼ Sell | Other | 82,812 | — | 1/1/2022 | View on chart |
| ATHS | ▼ Sell | Other | 30,043 | — | 1/1/2022 | View on chart |
| ATHS | ▲ Buy | Grant | 20,029 | $0 | 1/1/2022 | View on chart |
| ATHS | ▼ Sell | Other | 20,029 | — | 1/1/2022 | View on chart |
| ATHS | ▼ Sell | Open Market | 4,300 | $351K | 10/20/2021 | View on chart |
| ATHS | ▼ Sell | Open Market | 2,200 | $165K | 10/11/2021 | View on chart |
| ATHS | ▼ Sell | Open Market | 1,800 | $130K | 10/7/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Barclays Lifts MGIC Target to $29; AM Best Affirms Ratings
Barclays maintained an Equal-Weight rating on MGIC Investment while raising its price target to $29. In related news, AM Best affirmed the credit ratings of the company's operating subsidiaries. These updates provide a neutral backdrop as the stock trades near its 52-week low, with an average analyst target of $31.20.
Barclays Lifts MGIC Target to $29; AM Best Affirms Ratings. Barclays maintained an Equal-Weight rating on MGIC Investment while raising its price target to $29. In related news, AM Best affirmed the credit ratings of the company's operating subsidiaries. These updates provide a neutral backdrop as the stock trades near its 52-week low, with an average analyst target of $31.20.